The mpox outbreak in 2022 launched a vaccination campaign employing an existing vaccine with moderate protection, highlighting the lack of scalable Orthopoxvirus vaccines with optimal protection. In this issue of Cell, Zuiani et al. report pre-clinical findings of an mRNA-based mpox vaccine, paving the way for Phase I/II clinical trials.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cell.2024.02.011 | DOI Listing |
Publication Analysis
Top Keywords
mrna-based monkeypox
4
monkeypox virus
4
virus vaccine
4
vaccine prevents
4
prevents disease
4
disease non-human
4
non-human primates
4
primates mpox
4
mpox outbreak
4
outbreak 2022
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!